Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs
Expectations on mesenchymal stem cell (MSC) treatment are high, especially in the fields of sepsis, transplant medicine, and autoimmune diseases. Various pre-clinical studies have been conducted with encouraging results, although the mechanisms of action behind the observed immunomodulatory capacity...
Main Authors: | Andreas Robert Rudolf Weiss, Marc Hendrik Dahlke |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01191/full |
Similar Items
-
Editorial: Immunomodulation of MSCs in tissue repairing and regeneration
by: Yanwen Peng, et al.
Published: (2023-02-01) -
Senescence induces fundamental changes in the secretome of mesenchymal stromal cells (MSCs): implications for the therapeutic use of MSCs and their derivates
by: Yesuf Siraj, et al.
Published: (2023-05-01) -
Apoptotic MSCs and MSC-Derived Apoptotic Bodies as New Therapeutic Tools
by: Irina V. Kholodenko, et al.
Published: (2022-10-01) -
Progress and emerging techniques for biomaterial-based derivation of mesenchymal stem cells (MSCs) from pluripotent stem cells (PSCs)
by: Nityanand Prakash, et al.
Published: (2023-04-01) -
The Current Status of Mesenchymal Stromal Cells: Controversies, Unresolved Issues and Some Promising Solutions to Improve Their Therapeutic Efficacy
by: David García-Bernal, et al.
Published: (2021-03-01)